| Sep 16, 2013
| 3:33 PM
A decade ago, Taymour Tamaddon was an MBA. student with a background in physics trying to convince Baltimore-based money manager T. Rowe Price to hire him as an intern.
Not only did Price give him the internship and hire him later as a health care...
| Aug 27, 2012
| 3:29 PM
(Reuters) - U.S. health regulators on Monday approved Gilead Sciences Inc's four-drug combination pill to treat HIV, the virus that causes AIDS.
The four drugs in one pill, which was formerly called the Quad and had been considered one of Gilead's more...
| Jul 16, 2012
| 4:31 PM
The federal government has approved for the first time a drug that can prevent an HIV infection, a significant development for Baltimore where transmission rates for the virus remain high and growing.
The U.S. Food and Drug Administration approved...
| Jul 20, 2012
| 2:21 PM
NEW YORK (Reuters) - The World Health Organization has endorsed using HIV medicines among people who do not have the infection but are at high risk of getting it and suggested that poor and wealthy countries alike set up pilot projects to better...
| Jul 18, 2012
| 11:43 AM
LOS ANGELES/GENEVA (Reuters) - Fewer people infected with HIV globally are dying as more of them get access to crucial antiretroviral drugs, particularly in sub-Saharan Africa, the United Nations AIDS program said on Wednesday.
The United Nations...
| Oct 27, 2010
| 1:51 PM
Groups working on a gel to protect women from the AIDS virus say they are moving ahead to develop the product that was hailed as "groundbreaking" after a study on its effectiveness was released in July.
The developers, who met last week with the U.S....
| Jul 16, 2012
| 1:51 PM
LOS ANGELES -- Adults who do not have HIV but are at risk of getting the disease will now be able to take a drug to reduce their chance of getting infected.
For the first time, the U.S. Food and Drug Administration approved a drug for this use on Monday....
| Jun 14, 2010
| 4:06 PM
In a rare move, federal regulators are seeking to disqualify a prominent Chicago HIV doctor from future drug studies after they discovered his clinic committed one of the most grievous sins of medical research: submitting fictitious data in a drug trial....
| Jan 13, 2008
Q: What's with my shares of Mattel Inc.? Is the future bleak? --C.R., via the Internet
A: Shares of the world's largest toymaker reached a 52-week low this month following a lackluster holiday sales season and a year of recalls of millions of toys...
| Jul 19, 2010
| 4:11 PM
VIENNA, Austria-- A new topical gel has shown promise in helping to protect women from HIV infection, according to a study being presented at the International AIDS Conference in Vienna, Austria.
The gel contains the antiretroviral drug tenofovir,...